Cargando…
Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases
The World Health Organization (WHO) has reported that globally 235 million people suffer from chronic and other inflammatory diseases. The short half-lives of nonsteroidal anti-inflammatory drugs (NSAIDs) and their notoriety in causing gastrointestinal discomforts, warrants these drugs to be release...
Autores principales: | Baek, Jong-Suep, Yeo, Eng Wan, Lee, Yin Hao, Tan, Nguan Soon, Loo, Say Chye Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472418/ https://www.ncbi.nlm.nih.gov/pubmed/28652708 http://dx.doi.org/10.2147/DDDT.S133344 |
Ejemplares similares
-
Sustained-releasing hollow microparticles with dual-anticancer drugs elicit greater shrinkage of tumor spheroids
por: Baek, Jong-Suep, et al.
Publicado: (2017) -
Modulating Drug Release from Gastric-Floating Microcapsules through Spray-Coating Layers
por: Lee, Wei Li, et al.
Publicado: (2014) -
Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug
por: Ryu, Suji, et al.
Publicado: (2021) -
Lipid-Polymer Hybrid Nanoparticles Enhance the Potency
of Ampicillin against Enterococcus faecalis in a Protozoa Infection Model
por: Tan, Chuan Hao, et al.
Publicado: (2021) -
Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye
por: Fan, Yanliang, et al.
Publicado: (2019)